Corrigendum to PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study Volume 14, Issue 3, May–June 2020, Pages 322-330.e5
- Resource Type
- Erratum
- Source
- In
Journal of Clinical Lipidology September-October 2020 14(5):741-741 - Subject
- Language
- ISSN
- 1933-2874